CRISPR-based gene editing shows promise in treating rare form of blindness

FHS
May 6, 2024
6:43 pm

About 79% of clinical trial participants experienced measurable improvement after receiving experimental, CRISPR-based gene editing that is designed to fix a rare form of blindness, according to a paper published in the New England Journal of Medicine.

A presidential debate, GLP-1s for kids, and ultra-processed foods research

Good morning! Today STAT is publishing the final installment in the “Embedded Bias” series. My colleagues Usha and Katie have done some amazing reporting over

September 11, 2024

Study reveals health challenges faced by sandwich carers

People who care for both their children and older family members – also known as ‘sandwich carers’ – suffer from deterioration in both their mental

January 7, 2025

MS Risk Linked to Ancient Migrations

Genetic risk for multiple sclerosis (MS) was brought into Europe by sheep and cattle herders migrating from the east approximately 5,000 years ago, DNA profiles

January 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.